Understanding body and organ function in health and diseases requires a thorough knowledge of the molecular events that take place at the level of individual cells. These cellular processes are carried out by thousands of different molecules, from single proteins to sophisticated megadalton-sized protein complexes. How do these molecules work (individually or as part signaling pathways) to control cellular activities, and how are these molecular machineries dysregulated in various pathological states are the fundamental questions tackled by the teams in the Thematic Unit “Molecular Biology of Diseases (MBD)”. With the ultimate goal of translating molecular advances into novel therapeutic approaches the MBD brings together multifaceted and multidisciplinary group of researchers. Synergistic interactions and strong technological support provide an environment conducive to understanding the physiological and pathological functions of complex molecular machineries.
At the annual meeting of the BSCDB (Belgian Society of Cell Biology and Development), Sylvain Delaunay, a former doctoral student at the laboratory of Cancer Signaling (GIGA-MBD) who is currently in post-doctoral study at the University of Cambridge, received this prestigious award that rewards the work done during his PhD thesis at GIGA.